InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Capello Jeffrey d. Director active across 3 companies, notably AGIOS PHARMACEUTICALS, INC.. Cumulatively, 13 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €88k. Activity tracked since 13 June 2024. The latest transaction was filed on 27 October 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations
CAPELLO JEFFREY D has filed 13 reports in total, all within the recent sample covered here, with transactions mainly related to NEOGEN CORP, where he is a director, and AGIOS PHARMACEUTICALS, INC., where he is also a director. Over the period from 2024-06-17 to 2026-06-23, the buy volume reported in this recent sample is EUR 88287, and the most frequent transaction nature is Levée d'options.